Literature DB >> 7569117

The clinical and biochemical features of acute renal failure due to rhabdomyolysis.

G Woodrow1, A M Brownjohn, J H Turney.   

Abstract

Rhabdomyolysis caused 28 out of 903 (3.1%) of cases of severe acute renal failure (ARF) treated at Leeds General Infirmary over a 14-year period (1980-1993). The commonest cause of rhabdomyolysis was muscle compression, usually due to drug- or alcohol-induced coma. Other causes included fits, infection, acute limb ischemia, trauma, and heat stroke. Prognosis was relatively good, with a 78.6% survival rate and recovery of renal function to normal in all survivors who were followed up. The creatinine/urea ratio was higher in ARF due to rhabdomyolysis than in an unselected group of patients with other causes of ARF but not when the comparison was with sex- and age-matched controls with ARF. This suggests that this previously described feature of rhabdomyolysis simply reflects the increased muscle mass of a younger group of patients, rather than a specific effect of muscle damage. Clinical features of muscle damage were often absent and so the possibility of rhabdomyolysis should be considered in appropriate settings if the diagnosis is to be made early enough to administer treatment that may prevent ARF and the consequences of the compartment syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7569117     DOI: 10.3109/08860229509037610

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  14 in total

1.  Characteristic MR image finding of squatting exercise-induced rhabdomyolysis of the thigh muscles.

Authors:  Eung K Yeon; Kyung N Ryu; Hye J Kang; So H Yoon; So Y Park; Ji S Park; Wook Jin
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

2.  A risk prediction score for kidney failure or mortality in rhabdomyolysis.

Authors:  Gearoid M McMahon; Xiaoxi Zeng; Sushrut S Waikar
Journal:  JAMA Intern Med       Date:  2013-10-28       Impact factor: 21.873

Review 3.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

4.  Postoperative rhabdomyolysis following robotic renal and adrenal surgery: a cautionary tale of compounding risk factors.

Authors:  Russell S Terry; Travis Gerke; James B Mason; Matthew D Sorensen; Jason P Joseph; Philipp Dahm; Li-Ming Su
Journal:  J Robot Surg       Date:  2015-06-20

5.  Acute kidney injury after trauma: Prevalence, clinical characteristics and RIFLE classification.

Authors:  Krasnalhia Lívia S de Abreu; Geraldo B Silva Júnior; Adller G C Barreto; Fernanda M Melo; Bárbara B Oliveira; Rosa M S Mota; Natália A Rocha; Sônia L Silva; Sônia M H A Araújo; Elizabeth F Daher
Journal:  Indian J Crit Care Med       Date:  2010-07

Review 6.  Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review.

Authors:  Christian Nusshag; Markus A Weigand; Martin Zeier; Christian Morath; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-06-28       Impact factor: 5.923

7.  Acute rhabdomyolysis of the soleus muscle induced by a lightning strike: magnetic resonance and scintigraphic findings.

Authors:  Naofumi Watanabe; Tsutomu Inaoka; Noriyuki Shuke; Koji Takahashi; Tamio Aburano; Naoyuki Chisato; Hitoshi Nochi; Kazutomo Go
Journal:  Skeletal Radiol       Date:  2007-02-14       Impact factor: 2.128

8.  Risk factors for acute kidney injury in severe rhabdomyolysis.

Authors:  Eva Rodríguez; María J Soler; Oana Rap; Clara Barrios; María A Orfila; Julio Pascual
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

9.  Rhabdomyolysis and Acute Kidney Injury due to Severe Heat Stroke.

Authors:  Máximo H Trujillo; Carlos Fragachán G
Journal:  Case Rep Crit Care       Date:  2011-09-27

10.  Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke.

Authors:  Bancha Satirapoj; Suramanat Kongthaworn; Panbubpa Choovichian; Ouppatham Supasyndh
Journal:  BMC Nephrol       Date:  2016-06-06       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.